CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-11,272
-10,173
-12,615
-14,443
-12,625
Depreciation & amortization
14
14
14
12
14
Stock based compensation
263
263
398
355
385
Change in working capital
-1,301
-1,301
2,485
2,001
1,185
Accounts receivable
-
-
-
2,726
270
Accounts Payable
-58
-58
393
-1,595
1,085
Other working capital
-10,810
-10,810
-9,869
-12,089
-10,837
Other non-cash items
113
113
-46
1
-5
Net cash provided by operating activites
-10,801
-10,801
-9,858
-12,063
-10,834
Cash flows from investing activities
Investments in property, plant and equipment
-9
-9
-11
-26
-3
Purchases of investments
-
-
-14,500
0
0
Other investing activites
-
-
-
-
-250
Net cash used for investing activites
9,502
9,502
-14,511
-26
-253
Cash flows from financing activities
Debt repayment
-
-
-
-
-34
Common stock issued
0
0
20,457
17,683
10,167
Net cash used privided by (used for) financing activities
0
0
20,457
17,683
10,167
Net change in cash
-1,412
-1,412
-3,878
5,571
-918
Cash at beginning of period
4,390
4,390
8,268
2,697
3,615
Cash at end of period
2,978
2,978
4,390
8,268
2,697
Free Cash Flow
Operating Cash Flow
-10,801
-10,801
-9,858
-12,063
-10,834
Capital Expenditure
-9
-9
-11
-26
-3
Free Cash Flow
-10,810
-10,810
-9,869
-12,089
-10,837